Patents by Inventor Anne-Mieke Vandamme

Anne-Mieke Vandamme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Near full-genome assay of HCV drug resistance
    Patent number: 8911934
    Abstract: The invention relates to assays for characterization of genotypic mutations of Hepatitis C Virus (HCV) showing a resistance to anti-HCV drugs.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: December 16, 2014
    Assignees: Debiopharm SA, Katholieke Universiteit Leuven
    Inventors: Grégoire Vuagniaux, Jean-Maurice Dumont, Joke Snoeck, Sonia Van Dooren, Anne-Mieke Vandamme
  • NEAR FULL-GENOME ASSAY OF HCV DRUG RESISTANCE
    Publication number: 20140187765
    Abstract: Assays for characterization of genotypic mutations of Hepatitis C Virus (HCV) showing a resistance to anti-HCV drugs.
    Type: Application
    Filed: December 23, 2013
    Publication date: July 3, 2014
    Applicants: Katholieke Universiteit Leuven, Debiopharm SA
    Inventors: Gregoire Vuagniaux, Jean-Maurice Dumont, Joke Snoeck, Sonia Van Dooren, Anne-Mieke Vandamme
  • NEAR FULL-GENOME ASSAY OF HCV DRUG RESISTANCE
    Publication number: 20100311038
    Abstract: The invention relates to assays for characterization of genotypic mutations of Hepatitis C Virus (HCV) showing a resistance to anti-HCV drugs.
    Type: Application
    Filed: October 31, 2008
    Publication date: December 9, 2010
    Applicants: DE-BIOPHARM SA, KATHOLIEKE UNIVERSITEIT LEUVEN
    Inventors: Grégoire Vuagniaux, Jean-Maurice Dumont, Joke Snoeck, Sonia Van Dooren, Anne-Mieke Vandamme